Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Glaser

Showing results (71-80 of 97) with videos related to

Pageof 10
Sort By:
American Journal of Clinical Dermatology|May 22, 2019
A 44-Week Open-Label Study Evaluating Safety and Efficacy of Topical Glycopyrronium Tosylate in Patients with Primary Axillary HyperhidrosisDee Anna Glaser, Adelaide A Hebert, Alexander Nast, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 9, 2003
New loci regulating rat myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitisKristina Becanovic, Erik Wallstrom, Barbara Kornek, et al.
Journal of the American Academy of Dermatology|March 7, 2025
Sofpironium topical gel, 12.45%, for the treatment of axillary hyperhidrosis: Pooled efficacy and safety results from 2 phase 3 randomized, controlled, double-blind studiesDavid Pariser, Dee Anna Glaser, James Del Rosso, et al.
Alzheimer Disease and Associated Disorders|July 2, 2009
Frontotemporal dementia-amyotrophic lateral sclerosis complex is simulated by neurodegeneration with brain iron accumulationAlexander Frizell Santillo, Lena Skoglund, Maria Lindau, et al.
Plos One|May 30, 2019
Plasma protein profiling reveals candidate biomarkers for multiple sclerosis treatmentSahl Khalid Bedri, Ola B Nilsson, Katharina Fink, et al.
BMC Medical Genetics|December 3, 2009
Further analysis of previously implicated linkage regions for Alzheimer's disease in affected relative pairsElin S Blom, Vilmantas Giedraitis, Sampath Arepalli, et al.
Journal of Drugs in Dermatology : JDD|May 20, 2010
Randomized comparison of the safety and efficacy of tazarotene 0.1% cream and adapalene 0.3% gel in the treatment of patients with at least moderate facial acne vulgarisEmil Tanghetti, Sunil Dhawan, Lawrence Green, et al.
Alzheimer Disease and Associated Disorders|October 27, 2010
Novel progranulin mutation detected in 2 patients with FTLDLena Skoglund, Toshifumi Matsui, Stefanie H Freeman, et al.
Dementia and Geriatric Cognitive Disorders|November 27, 2009
No evidence of PGRN or MAPT gene dosage alterations in a collection of patients with frontotemporal lobar degenerationLena Skoglund, Sofie Ingvast, Toshifumi Matsui, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|August 28, 2024
A Review of Current Data on Duration of Effect in Glabellar Lines After Treatment With AbobotulinumtoxinA 50 UJoel L Cohen, Sue Ellen Cox, Dee Anna Glaser, et al.
Pageof 10

Showing results (71-80 of 97) with videos related to

Sort By:
Pageof 10
American Journal of Clinical Dermatology|May 22, 2019
A 44-Week Open-Label Study Evaluating Safety and Efficacy of Topical Glycopyrronium Tosylate in Patients with Primary Axillary HyperhidrosisDee Anna Glaser, Adelaide A Hebert, Alexander Nast, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 9, 2003
New loci regulating rat myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitisKristina Becanovic, Erik Wallstrom, Barbara Kornek, et al.
Journal of the American Academy of Dermatology|March 7, 2025
Sofpironium topical gel, 12.45%, for the treatment of axillary hyperhidrosis: Pooled efficacy and safety results from 2 phase 3 randomized, controlled, double-blind studiesDavid Pariser, Dee Anna Glaser, James Del Rosso, et al.
Alzheimer Disease and Associated Disorders|July 2, 2009
Frontotemporal dementia-amyotrophic lateral sclerosis complex is simulated by neurodegeneration with brain iron accumulationAlexander Frizell Santillo, Lena Skoglund, Maria Lindau, et al.
Plos One|May 30, 2019
Plasma protein profiling reveals candidate biomarkers for multiple sclerosis treatmentSahl Khalid Bedri, Ola B Nilsson, Katharina Fink, et al.
BMC Medical Genetics|December 3, 2009
Further analysis of previously implicated linkage regions for Alzheimer's disease in affected relative pairsElin S Blom, Vilmantas Giedraitis, Sampath Arepalli, et al.
Journal of Drugs in Dermatology : JDD|May 20, 2010
Randomized comparison of the safety and efficacy of tazarotene 0.1% cream and adapalene 0.3% gel in the treatment of patients with at least moderate facial acne vulgarisEmil Tanghetti, Sunil Dhawan, Lawrence Green, et al.
Alzheimer Disease and Associated Disorders|October 27, 2010
Novel progranulin mutation detected in 2 patients with FTLDLena Skoglund, Toshifumi Matsui, Stefanie H Freeman, et al.
Dementia and Geriatric Cognitive Disorders|November 27, 2009
No evidence of PGRN or MAPT gene dosage alterations in a collection of patients with frontotemporal lobar degenerationLena Skoglund, Sofie Ingvast, Toshifumi Matsui, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|August 28, 2024
A Review of Current Data on Duration of Effect in Glabellar Lines After Treatment With AbobotulinumtoxinA 50 UJoel L Cohen, Sue Ellen Cox, Dee Anna Glaser, et al.
Pageof 10